Vivimed Labs Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Vivimed Labs Limited's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 72% to $2,372,871,000. The net income raised on -$676,502,000 and profit margin reached -29%. Total operating expenses were $1,088,773,000.

Profit Margin

Vivimed Labs Limited (NSE:VIVIMEDLAB.NS): Profit margin
2010 3.43B 310.11M 9.03%
2011 4.16B 488.31M 11.74%
2012 6.68B 631.37M 9.45%
2015 13.80B 720.5M 5.22%
2016 13.45B 836.73M 6.22%
2018 11.85B 779.43M 6.57%
2019 13.15B 573.65M 4.36%
2021 8.61B -777.95M -9.03%
2022 2.37B -676.50M -28.51%

VIVIMEDLAB.NS Income Statement (2010 – 2021)

2021 2020 2018 2017 2015 2014 2012 2011 2010
Revenue
Revenue
2.37B8.61B13.15B11.85B13.45B13.80B6.68B4.16B3.43B
Cost of revenue
1.53B3.54B6.52B5.42B6.86B6.46B3.37B2.72B2.30B
Gross profit
838.04M5.06B6.63B6.43B6.59B7.33B3.30B1.43B1.12B
Operating exp.
Research and development
3.37M264.37M363.04M747.7M628.22M00122.15M33.65M
Selling and marketing
2.64M069.17M80.24M208.57M0000
Total operating expenses
1.08B5.28B5.35B4.87B4.99B5.77B2.24B676.53M519.44M
Operating income
-250.73M-68.52M1.27B1.56B1.59B775.37M1.06B758.58M608.73M
Other income (expenses), net
-397.6M-817.55M-611.14M-702.9M-815.67M-2.76B-283.75M205.96M212.28M
Income before tax
-648.33M-757.65M660.45M857.11M999.32M775.37M778.15M552.62M396.45M
Income tax expense
28.17M20.29M86.8M96.21M162.59M54.87M146.79M64.31M86.34M
Net income
-676.50M-777.95M573.65M779.43M836.73M720.5M631.37M488.31M310.11M
Earnings per share
Basic EPS
-8.16-9.386.959.4451.648.899.069.606.22
Diluted EPS
-8.16-9.386.679.3350.098.637.868.386.22
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source